Private Capital Group, LLC Gilead Sciences, Inc. Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 1,912 shares of GILD stock, worth $225,329. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,912

Previous 2,300 16.87%

Holding current value

$225,329

Previous $137,000 13.87%

% of portfolio

0.09%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $22,395 - $25,223	-388 Reduced 16.87%	1,912 $118,000
Q1 2022 Apr 21, 2022	SELL	$57.92 - $72.58 $20,445 - $25,620	-353 Reduced 13.31%	2,300 $137,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $8,888 - $10,088	-137 Reduced 4.91%	2,653 $193,000
Q3 2021 Oct 13, 2021	BUY	$67.69 - $73.03 $12,116 - $13,072	179 Added 6.86%	2,790 $195,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $15,613 - $17,060	-246 Reduced 8.61%	2,611 $180,000
Q1 2021 Apr 12, 2021	SELL	$60.0 - $68.46 $19,020 - $21,701	-317 Reduced 9.99%	2,857 $185,000
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $30,817 - $35,115	-544 Reduced 14.63%	3,174 $185,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $153,200 - $192,623	-2,467 Reduced 39.89%	3,718 $235,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $24,450 - $28,392	-338 Reduced 5.18%	6,185 $476,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $94,633 - $121,212	1,511 Added 30.15%	6,523 $488,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $246,603 - $271,255	-4,002 Reduced 44.4%	5,012 $325,000
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $265,417 - $292,974	4,246 Added 89.05%	9,014 $571,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $236,838 - $265,586	-3,828 Reduced 44.53%	4,768 $338,000
Q1 2019 Apr 26, 2019	BUY	$62.53 - $70.05 $76,911 - $86,161	1,230 Added 16.7%	8,596 $559,000
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $47,766 - $62,331	-789 Reduced 9.68%	7,366 $461,000
Q3 2018 Oct 31, 2018	BUY	$71.28 - $78.92 $154,820 - $171,414	2,172 Added 36.3%	8,155 $630,000
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $9,732 - $11,352	150 Added 2.57%	5,983 $423,000
Q1 2018 May 16, 2018	BUY	$72.84 - $88.8 $96,658 - $117,837	1,327 Added 29.45%	5,833 $440,000
Q4 2017 May 18, 2018	BUY	$71.15 - $83.52 $306,371 - $359,637	4,306 Added 2153.0%	4,506 $323,000
Q4 2017 Mar 07, 2018	BUY	$71.15 - $83.52 $14,230 - $16,704	200	200 $5,000

Others Institutions Holding GILD

# of Institutions

2,326

Shares Held

1.02B

Call Options Held

12.1M

Put Options Held

9.13M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $148B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Gilead Sciences, Inc. Transaction History